Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Media coverage

• Title	Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	18/07/22
  Persons	Deirdre Cohen